United Kingdom· GB-APID-15454711000001106
ReFacto AF 500unit powder and solvent for solution for injection vials
A moroctocog alfa product containing moroctocog alfa, registered in United Kingdom by Pfizer Ltd. The same ATC class is registered in 2 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Moroctocog alfa is registered in 2 of 19 countries.
Countries holding a registration under ATC B02BD31 (moroctocog alfa), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 1 of them publish a price we can compare per daily dose
Moroctocog alfa · ATC B02BD31
2 / 19 countries
- Franceprice
- United Kingdom
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Moroctocog alfa
- Manufacturer
- Pfizer Ltd
- Country
- United Kingdom (GB)
- ATC code
- B02BD31
- ATC class
- Moroctocog alfa
- Defined daily dose
- 1 TSD, E
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 3
- gtin5010981002943
- gtin5415062341001
- gtin5415062308721
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Moroctocog alfa in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaREFACTO AFPfizer Europe MA EEIG, Bruxelles
- SpainREFACTO AF 1000 UI POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE EN JERINGA PRECARGADAPfizer Europe Ma Eeig
- FinlandReFacto AFPfizer Europe MA EEIG
- SwedenReFacto AF 1000 IE Pulver och vätska till injektionsvätska, lösningPfizer Europe MA EEIG
- BelgiumReFacto AF 1000 IUPfizer Europe MA
- NetherlandsReFacto AF, 1000 IE poeder en oplossing voor injectiePfizer Europe MA EEIG
- ItalyREFACTO AF*1 flaconcino EV 1.000 Unita' Internazionali + 1 siringa 4 mlPFIZER EUROPE MA EEIG
- CanadaXYNTHAPFIZER CANADA ULC
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Refacto Af
- Liechtenstein · Refacto Af
- Norway · Refacto Af
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/fb94dedb-5592-45fa-8968-0bf4e531010a GET /v1/drugs/fb94dedb-5592-45fa-8968-0bf4e531010a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "15454711000001106",
"desc": "ReFacto AF 500unit powder and solvent for solution for injection vials (Pfizer Ltd)",
"form": "Powder and solvent for solution for injection",
"vpid": "4841611000001100",
"source": "dmd",
"vtm_id": "776826000",
"strength": "500 unit",
"substance": "Moroctocog alfa",
"ingredient": "Moroctocog alfa",
"supplier_code": "2082201000001106"
}See everything about moroctocog alfa.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.